reported that BALB/c mice previously sensitized lost weight after challenging with OVA, which remained until the end of the experiment. In normal conditions, the number of mast cells in the intestine is relatively constant, but hyperplasia can be observed during inflammatory reactions or during stages of remodeling/repair of inflammatory
disorders . As a result of the food enteropathy developed upon administration of OVA, we observed increased number of mast cells in the small intestine of PC group. However, no alterations were observed in the mast cell population from the Bov group. RG7112 order Bacterial products or cell components may induce metaplasia, proliferation and hypersecretion of goblet cells . In this study, animals treated with OVA showed reduced number of goblet cells in the small intestine, and a reduction in the secretion of acidic and neutral mucins. In contrast, the administration of bovicin HC5 did not alter the total number or the pattern of goblet cell secretion. The mucus protects the intestinal wall by limiting the absorption of antigens, and therefore, the hypersecretion of mucopolysaccharides was expected at the PC group, as a characteristic of allergic inflammation
and as a result of increased IL-13 expression ; therefore, the reduction in the number of cells responsible for mucus secretion observed in PC group may not be related to the reduction in the secretion process per se, but BYL719 molecular weight to the limited count fields resulting from the destruction of the villi observed in PC group. Similar to goblet cells, Paneth cells also play an important role in host intestinal defense mechanisms, contributing to the
maintenance of the gastrointestinal HSP90 barrier by secreting antimicrobial peptides and other compounds in response to bacteria and bacterial antigens [22, 23]. The presence of antigens in the gastrointestinal tract also influence the expression and activity of key proteins involved in the regulation of cell proliferation . Hypertrophy of Paneth cells and increased check details mitotic activity were observed in Bov and PC groups, indicating that despite the loss of villi architecture, secretion of antimicrobial compounds and tissue repair systems remained active, probably as a response to the injuries caused by bovicin HC5 and OVA in the small intestine. Our results indicate that the effects of bovicin HC5 and ovalbumin administration are more pronounced in the intestine, which can explain the significant reduction in spleen cellularity observed in Bov and PC groups: immune cells probably migrated from the spleen to the intestine, where the main effects were observed. OVA administration modulated the gut mucosal immunity in BALB/c mice towards significant TH2-polarized response, increasing the relative expression of IL-4, IL-5 and IL-13 mRNA. Goya et al. also observed increased mRNA levels of the TH2 cytokines IL-4, IL-5 and IL-13, as well as a decrease of INF-γ expression in the lungs of OVA-treated mice.